Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating income | -$34.0M | -$30.9M | -$47.5M | -$91.1M | -$130M | -$236M |
| Net income | -$40.8M | -$36.0M | -$46.8M | -$76.4M | -$109M | -$212M |
| EPS (diluted) | -$2.70 | -$40.95 | -$45.05 | -$3.42 | -$3.96 | -$6.01 |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$32.7M | -$27.5M | -$42.3M | -$73.5M | -$93.9M | -$180M |
| Capital expenditures | $22.0K | $68.0K | $151K | $89.0K | $505K | $933K |
| Free cash flow | -$32.7M | -$27.6M | -$42.4M | -$73.6M | -$94.4M | -$181M |
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.50M | $88.0M | $195M | $360M | $192M | $91.1M |
| Total assets | $8.32M | $92.4M | $200M | $368M | $497M | $807M |
| Total liabilities | $30.2M | $14.8M | $23.6M | $22.9M | $53.2M | $67.1M |
| Long-term debt | $14.0M | — | — | $0.00 | $28.3M | $29.2M |
| Shareholders' equity | -$28.8M | -$64.2M | $177M | $345M | $444M | $740M |
| Retained earnings | -$113M | -$65.4M | -$112M | -$189M | -$298M | -$510M |
| Shares (wtd avg diluted) | 15.6M | 878K | 1.04M | 22.3M | 27.6M | 35.3M |
Every figure is extracted from Disc Medicine, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.